This is Clinical Product Thinking 🧠, a weekly newsletter featuring practical tips, frameworks and strategies from the front line of clinical product.
Welcome, friends. This is issue No. 64 of Clinical Product Thinking. This week, I’m asking for your help with the State of Clinical Product 2026!
Last year, I published the first State of Clinical Product report, drawing from conversations with more than 100 clinical product managers, founders, Clinical Safety Officers, product leaders and regulators. It looked at the industry’s biggest challenges, the hiring market and four predictions for 2026.
This year, I’d love your help creating the State of Clinical Product 2026. As a thank you, everyone who completes it and leaves their email will be entered into a draw for one of two 45-minute 1:1 strategy calls with me. Bring whatever you’re working on: a product decision, a clinical safety question, a hiring plan or your next career move.
👉 Take the survey (about 2 minutes, anonymous)
What we found last year
These were the six challenges that came up again and again:
Regulation and speed. Moving fast and staying compliant, especially with AI.
Influence without authority. Senior in responsibility, junior in formal power.
Translating clinical reality into product. Turning messy practice into clean product logic.
Clinical safety arriving too late. Treated as a gate at the end of the build.
Knowing what evidence is enough. Pressure to prove impact with unclear standards.
Role and career uncertainty. A discipline still forming, with few benchmarks.
The pattern underneath all six was that many clinical product managers were carrying systemic responsibility in organisations that hadn’t yet built the systems to support them.
I’d like to know whether that’s still true, and which of the six matter most to you now.
Did my predictions hold up?
Last time, I made four predictions for 2026. Here’s what I’ve seen since, and what the survey will test.
1. Director and VP clinical product roles become standard. There are early signs. Dyad advertised a Chief Clinical Product Officer with the VP of Engineering reporting to the role, and AIOS described its Head of Clinical Product as a route to a future CPO role. Two job adverts make a trend look tempting. The survey will show how common these roles really are.
2. AI becomes core infrastructure for clinical product work. Job descriptions now ask clinicians to monitor and test AI tools. I’d like to know how many of you are building AI into products, and how many are already using it in your own safety and product work.
3. Clinical product formalises as a function. Last week’s issue was about the signs that a company needs one. The survey asks how big clinical product teams are, who they report to and who signs off clinical safety.
4. A shared career framework starts to emerge. The five archetypes were my attempt to describe the different jobs hiding under one title. Salaries are the missing piece. There’s still no open benchmark for clinical product pay, so the survey includes an optional, anonymous salary question.
What the survey covers
Your role, clinical background and the kind of organisation you work in
How clinical product is set up where you work: team size, reporting line and safety sign-off
How AI shows up in your work
Your three biggest challenges right now
Your prediction for 2027
Salary band (optional)
It takes a couple of minutes. Answers are anonymous and only reported in aggregate. If you leave your email at the end, I’ll send you the full report before it’s published and you’ll be in the draw for a strategy call.
The survey closes on Sunday 6 December. I’ll contact the two winners the following week, and the State of Clinical Product 2026 will land in this newsletter later in December.
Who should fill it in
Anyone working in or around clinical product: clinical product managers at any level, product managers in healthtech, Clinical Safety Officers, founders, and clinicians trying to move into the field. The more varied the answers, the more useful the picture will be for everyone.
If you know someone whose view should be in the report, please forward this email to them.
👉 Take the survey and be in with a chance of a 1:1 strategy call
Draw terms: two winners will be picked at random from everyone who completes the survey and leaves an email by 23:59 on Sunday 6 December 2026. Winners will be contacted by email within a week and can book a 45-minute call in January or February 2027. No cash alternative.
The takeaway
Last year’s report highlighted some of the challenges facing people working in clinical product. This year’s survey aims to build a clearer picture of how the field is developing, from team structures and responsibilities to salaries and emerging challenges. The more responses we get, the more useful the findings will be for everyone working in the field. Thank you for being a part!
That’s all for this week. See you next time! 👋
🤝 Work with me | 📅 Attend an event | ✍️ Send a message
Written by Dr Louise Rix, Clinical Product, AI, doctor and ex-VC. Passionate about all things healthcare, healthtech and clinical product (…obviously). Based in London. You can find me on LinkedIn & Instagram.
Made with 💜 for better, safer HealthTech.



The point that clinical product managers often carry system-level responsibility without the organisation built to support them is a useful framing. A clearer picture of team structures and pay could help clinicians judge what these roles involve before making the move into health tech.